Art

J-GLOBAL ID：201502206767243429   Reference number：15A0944821

A clinical prediction model for infusion reaction to rituximab

Rituximabによるinfusion reactionのリスク因子を考慮した投与基準の確立

Author (8)： UCHIIKE Akihiro (Dep. of Pharmacy Nihon Univ. Itabashi Hospital) ,  HAYAMA Tatsuya (Dep. of Pharmacy Nihon Univ. Itabashi Hospital) ,  MIURA Katsuhiro (Nihon Univ. School of Medicin) ,  TSUTSUMI Daisuke (Dep. of Pharmacy Nihon Univ. Itabashi Hospital) ,  HAYASAKA Masatoshi (Dep. of Pharmacy Nihon Univ. Itabashi Hospital) ,  HATTA Yoshihiro (Nihon Univ. School of Medicin) ,  TAKEI Masami (Nihon Univ. School of Medicin) ,  YOSHIDA Yoshikazu (Dep. of Pharmacy Nihon Univ. Itabashi Hospital)
Material： 日本臨床腫瘍学会学術集会(CD-ROM)  (Program and Abstracts. Annual Meeting of Japanese Society of Medical Oncology (CD-ROM))
Volume： 13th  Page： ROMBUNNO.O1-6-3  Publication year： 2015 
JST Material Number： L7804B  Document type： Proceedings
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *allergic reaction ,...
Semi thesaurus term： ROC analysis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0944821&from=J-GLOBAL&jstjournalNo=L7804B") }}

JST classification (3)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Terms in the title (3)： rituximab ,  リスク因子 ,  投与